Publications
du
reseau de recherches sur l’Inflammation
Cliquez sur le nom de l’auteur
pour demander un tiré-à-part.
2000 2001 2002 2003 2004 2005 2006 2007 2008
Androutsou ME, Saifeddine M, Hollenberg MD, Matsoukas J, Agelis G. 2009. Design, synthesis and biological evaluation of non-peptide PAR(1) thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity. Amino Acids. [Epub ahead of print] Auge C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N. 2009. Protease-activated receptor-4 (PAR(4)): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol Motil. [Epub ahead of print] Christianson JA, Bielefeldt K, Altier C, Cenac N, Davis BM, Gebhart GF, High KW, Kollarik M, Randich A, Undem B, Vergnolle N. 2009. Development, plasticity and modulation of visceral afferents. Brain Res Rev. 60:171-186. Dale CS, Altier C, Cenac N, Giorgi R, Juliano MA, Juliano L, Zamponi GW, Vergnolle N. 2009. Analgesic properties of S100A9 C-terminal domain: a mechanism dependent on calcium channel inhibition. Fundam Clin Pharmacol. 23:427-438. Georgy SR, Pagel CN, Wong DM, Sivagurunathan S, Loh LH, Myers DE, Hollenberg MD, Pike RN, Mackie EJ. 2009. Proteinase-activated receptor-2 and mouse osteoblasts: regulation of cell function and lack of specificity of PAR-activating peptides. Clin Exp Pharmacol Physiol. [Epub ahead of print] Gashev AA, Davis MJ, Gasheva OY, Nepiushchikh ZV, Wang W, Dougherty P, Kelly KA, Cai S, von der Weid PY, Muthuchamy M, Meininger CJ, Zawieja DC. 2009. Methods for Lymphatic Vessel Culture and Gene Transfection. Microcirculation. 22:1-14. Helyes Z, Sandor K, Borbely E, Tekus V, Pinter E, Elekes K, Toth DM, Szolcsanyi J, McDougall JJ. 2009. Involvement of transient receptor potential vanilloid 1 receptors in protease-activated receptor-2-induced joint inflammation and nociception. Eur J Pain. [Epub ahead of print]
Hollenberg MD.
2009. Professor Karl Lederis (1920-2007): always fishing for new ideas.
Gen Comp Endocrinol.
164:4-5. Imtiaz MS, von der Weid PY, van Helden DF. Synchronization of Ca(2+) oscillations: a coupled oscillator-based mechanism in smooth muscle. FEBS J. 2009 Nov 6. [Epub ahead of print] Kalischuk LD, Buret AG. A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? Am J Physiol Gastrointest Liver Physiol. 2009 Oct 29. [Epub ahead of print] Kalischuk LD, Inglis GD, Buret AG. 2009. Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Gut Pathog. 1:2. Kaufmann R, Oettel C, Horn A, Halbhuber KJ, Eitner A, Krieg R, Katenkamp K, Henklein P, Westermann M, Böhmer FD, Ramachandran R, Saifeddine M, Hollenberg MD, Settmacher U. 2009. Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor 2-mediated hepatocellular carcinoma cell invasion. Carcinogenesis. 30:1487-1496. Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, Andrade-Gordon P, Boullier S, Rousset P, Vergnolle N, Riteau B. 2009. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol. 182:7795-7802. Lapointe TK, O'Connor PM, Buret AG. 2009. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrhea. Lab Invest. 89(9):964-970. Martin GR, McKnight GW, Dicay MS, Coffin CS, Ferraz JG, Wallace JL. 2009. Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Dig Liver Dis. [Epub ahead of print] Martin L, Auge C, Boue J, Buresi MC, Chapman K, Asfaha S, Andrade-Gordon P, Steinhoff M, Cenac N, Dietrich G, Vergnolle N. 2009. Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways. Pain. [Epub ahead of print] McDougall JJ, Andruski B, Schuelert N, Hallgrimsson B, Matyas JR. 2009. Unravelling the relationship between age, nociception and joint destruction in naturally occurring osteoarthritis of Dunkin Hartley guinea pigs. Pain. 141:222-232. McDougall JJ, Zhang C, Cellars L, Joubert E, Dixon CM, Vergnolle N. 2009. Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice. Arthritis Rheum. 60:728-737. McKay DM, Wallace JL. 2009. Acetic acid induced ulceration in rats is not affected by infection with Hymenolepis diminuta. J Parasitol. 95:481-482. Perini RF, Camara PR, Ferraz JG. 2009. Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice. Nat Clin Pract Gastroenterol Hepatol. 6:150-158. Pittman QJ, Hollenberg MD. 2009. Urotensin I-CRF-Urocortins: A mermaid's tail. Gen Comp Endocrinol. 164:7-14. Ramachandran R, Mihara K, Mathur M, Rochdi MD, Bouvier M, Defea K, Hollenberg MD. 2009. Agonist-biased signaling via Proteinase Activated Receptor-2: differential activation of calcium and MAPkinase pathways. Mol Pharmacol. 76(4):791-801. Roifman I, Sun YC, Fedwick JP, Panaccione R, Buret AG, Liu H, Rostom A, Anderson TJ, Beck PL. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 7:175-182. Russell FA, McDougall JJ. 2009. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation. Inflamm Res. 58:119-126. Sandor K, Bolcskei K, McDougall JJ, Schuelert N, Reglodi D, Elekes K, Petho G, Pinter E, Szolcsanyi J, Helyes Z. 2009. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice. Pain. 141:143-150. Schuelert N, McDougall JJ. 2009. Grading of monosodium iodoacetate-induced osteoarthritis reveals a concentration-dependent sensitization of nociceptors in the knee joint of the rat. Neurosci Lett. 465(2):184-188. Swystun VA, Renaux B, Moreau F, Wen S, Peplowski MA, Hollenberg MD, MacNaughton WK. 2009. Serine proteases decrease intestinal epithelial ion permeability by activation of PKC{zeta} Am J Physiol Gastrointest Liver Physiol. 297:G60-G70. van der Merwe JQ, Moreau F, MacNaughton WK. 2009. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms. Am J Physiol Gastrointest Liver Physiol. 296:G1258-G1266. van der Merwe JQ, Ohland CL, Hirota CL, MacNaughton WK. 2009. Prostaglandin E2 derived from cyclooxygenases 1 and 2 mediates intestinal epithelial ion transport stimulated by the activation of protease-activated receptor 2. J Pharmacol Exp Ther. 329:747-752. Vergnolle N. 2009. Visceral afferents: What role in post-inflammatory pain? Auton Neurosci. [Epub ahead of print] Vergnolle N. 2009. Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Ther. 123:292-309. Wallace JL. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. 2009. Antioxid Redox Signal. [Epub ahead of print] Wallace JL, Viappiani S, Bolla M. 2009. Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis. Trends Pharmacol Sci. 30:112-117. Wallace JL, Vong L, McKnight W, Dicay M, Martin GR. 2009. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology. 137:569-578, 578.e1. Wang H, Zhang R, Wen S, McCafferty DM, Beck PL, MacNaughton WK. 2009. Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis. J Mol Med. 87:435-445. Wilson BJ, Harada R, LeDuy L, Hollenberg MD, Nepveu A. 2009. CUX1 transcription factor is a downstream effector of the proteinase-activated receptor 2 (PAR2). J Biol Chem. 284:36-45. Xue M, Hollenberg MD, Demchuk A, Yong VW. 2009. Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. Stroke. 40:2199-2204. Zhu Y, Vergote D, Pardo C, Noorbakhsh F, McArthur JC, Hollenberg MD, Overall CM, Power C. 2009. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J. [Epub ahead of print] Alexander CL, Urbanski SJ, Hilsden R, Rabin H, MacNaughton WK, Beck PL. 2008. The risk of gastrointestinal malignancies in cystic fibrosis Case report of a patient with a near obstructing villous adenoma found on colon cancer screening and Barrett's esophagus. J Cyst Fibros. 7:1-6. Alier KA, Endicott JA, Stemkowski PL, Cenac N, Cellars L, Chapman K, Andrade-Gordon P, Vergnolle N, Smith PA. 2008. Intrathecal administration of proteinase-activated receptor-2 agonists produces hyperalgesia by exciting the cell bodies of primary sensory neurons. J Pharmacol Exp Ther. 324:224-233. Andruski B, McCafferty DM, Ignacy T, Millen B, McDougall JJ. 2008. Leukocyte trafficking and pain behavioural responses to a hydrogen sulphide donor in acute monoarthritis. Am J Physiol Regul Integr Comp Physiol. 295:R814-R820. Beye JA, Hart DA, Bray RC, McDougall JJ, Salo PT. 2008. Injury-induced changes in mRNA levels differ widely between anterior cruciate ligament and medial collateral ligament. Am J Sports Med. 6:1337-1346. Buret AG. 2008. Pathophysiology of enteric infections with Giardia duodenalius. Parasite. 15:261-265. Camara PR, Ferraz GJ, Franco-Penteado CF, Sbragia-Neto L, Meirelles LR, Teixeira SA, Muscara MN, Velloso LA, Antunes E, Ferraz JG. 2008. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats. Eur J Pharmacol. 589:245-250. Cenac N, Altier C, Chapman K, Liedtke W, Zamponi G, Vergnolle N. 2008. Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms. Gastroenterology. 135:937-46, 946.e1-2. Chavez-Pina AE, Vong L McKnight W, Dicay M, Zanardo RCO, Ortiz MI, Castañeda-Hernandez G, Wallace JL. 2008. Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. Br J Pharmacol. 155:857-864. Chin AC, Lee WY, Nusrat A, Vergnolle N, Parkos CA. 2008. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. J Immunol. 181:5702-5710. Dale C, Vergnolle N. 2008. Protease signaling to g protein-coupled receptors: implications for inflammation and pain. J Recept Signal Transduct Res. 28:29-37. Dudar GK, D'Andrea LD, Di Stasi R, Pedone C, Wallace JL. 2008. A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner. Am J Physiol Gastrointest Liver Physiol. 295:G374-G381. Feld M, Shpacovitch VM, Ehrhardt C, Kerkhoff C, Hollenberg MD, Vergnolle N, Ludwig S, Steinhoff M. 2008. Agonists of proteinase-activated receptor-2 enhance IFN-γ inducible effects on human monocytes: Role in influenza A infection. J Immunol. 180:6903-6910. Flynn AN, Buret AG. Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection. Microb Pathog. 45:98-104. Flynn AN, Buret AG. 2008. Caspases-3, -8, and -9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability. Microb Pathog. 44:311-319. Hollenberg MD, Renaux B, Hyun E, Houle S, Vergnolle N, Saifeddine M, Ramachandran R. 2008. Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for proteinase-activated receptor 2 (PAR2): binding and visualization. J Pharmacol Exp Ther. 326:453-462. Hunter DJ, McDougall JJ, Keefe FJ. The symptoms of osteoarthritis and the genesis of pain. Rheum Dis Clin North Am. 34:623-643. Hyun E, Andrade-Gordon P, Steinhoff M, Vergnolle N. 2008. Protease-activated receptor-2 activation: a major role in intestinal inflammation. Gut. 57:1222-1229. Jackson SC, Beck P, Buret AG, O'Connor PM, Meddings J, Pineo G, Poon MC. 2008. Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura. Int J Hematol. 88:212-218. Lamb-Rosteski JM, Kalischuk LD, Inglis GD, Buret AG. 2008. Epidermal growth factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier function, and Escherichia coli translocation. Infect Immun. 76:3390-3398. Liu H, Schuelert N, McDougall JJ, Lee SS. 2008. Central neural activation of hyperdynamic circulation in portal hypertensive rats depends on vagal afferent nerves. Gut. 57:966-973. Martin GR, Perretti M, Flower RJ, Wallace JL. 2008. Annexin-1 modulates repair of gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol. 294:G764-769. McDougall JJ, Yu V, Thomson J. 2008. In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints. Br J Pharmacol. 153:358-366. Miller MJ, Reuter BK, Wallace JL, Sharkey KA. 2008. A unique therapeutic approach to emesis and itch with a proanthocyanidin-rich genonutrient. J Transl Med. 6:3. Mrsny RJ, Brown GT, Gerner-Smidt K, Buret AG, Meddings JB, Quan C, Koval M, Nusrat A. 2008. A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am J Pathol. 172:905-915. O'Hara JR, Buret AG. Mechanisms of intestinal tight junctional disruption during infection. Front Biosci. 13:7008-7021. Oliveira MS, de O Barreto E, Zamuner S, Pires AL, Ferreira TP, Cordeiro RS, Lagente V, Martins MA, Wallace JL, E Silva PM. 2008. Suppressive effects of nitric oxide-releasing prednisolone NCX-1015 on the allergic pleural eosinophil recruitment in rats. Clin Exp Allergy. 38:1830-1837. Paszcuk AF, Quintao NL, Fernandes ES, Juliano L, Chapman K, Andrade-Gordon P, Campos MM, Vergnolle N, Calixto JB. 2008. Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw. Eur J Pharmacol. 581:204-215. Schuelert N, McDougall JJ. 2008. Cannabinoid-mediated antinociception is enhanced in rat osteoarthritic knees. Arthritis Rheum. 58:145-153. van der Merwe JQ, Hollenberg MD, MacNaughton WK. 2008. EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 294:G441–G451. Vergnolle N. 2008. Proteinase-activated receptors (PARs) in infection and inflammation in the gut. Int J Biochem Cell Biol. 40:1219-1227. Vergnolle N. 2008. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil. 20:73-80. von der Weid P-Y, Rahman M, Imtiaz MS, F van Helden DF. 2008. Spontaneous transient depolarizations in lymphatic vessels of the guinea pig mesentery - pharmacology and implication for spontaneous contractility. Am J Physiol Heart Circ Physiol. 295:H1989-H2000. Wallace JL. 2008. Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why doesn't the stomach digest itself? Physiol Rev. 88:1547-1565. Wallace JL, Vong L. 2008. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs. Curr Opin Investig Drugs. 9:1151-1156. Wang H, Wen S, Bunnett NW, Leduc R, Hollenberg MD, MacNaughton WK. 2008. Proteinase activated-receptor-2 induces cyclooxygenase-2 expression through beta -catenin and cyclic AMP response element binding protein. J Biol Chem. 283:809-815. Yu LC, Huang CY, Kuo WT, Sayer H, Turner JR, Buret AG. 2008. SGLT-1-mediated glucose uptake protects human intestinal epithelial cells against Giardia duodenalis-induced apoptosis. Int J Parasitol. 38:923-934. Afkhami-Goli A, Noorbakhsh F, Keller AJ, Vergnolle N, Westaway D, Jhamandas JH, Andrade-Gordon P, Hollenberg MD, Arab H, Dyck RH, Power C. 2007. Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. 2007. J Immunol. 179:5493-5503. Altier C, Dale CS, Kisilevsky AE, Chapman K, Castiglioni AJ, Matthews EA, Evans RM, Dickenson AH, Lipscombe D, Vergnolle N, Zamponi GW. 2007. Differential role of N-type calcium channel splice isoforms in pain. J Neurosci. 27:6363-6373. Asfaha S, Cenac N, Houle S, Altier C, Papez MD, Nguyen C, Steinhoff M, Chapman K, Zamponi GW, Vergnolle N. 2007. Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br J Pharmacol. 150:176-185. Buret AG. 2007. Mechanisms of epithelial dysfunction in giardiasis. Gut. ;56:316-317. Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW, Sharkey KA, Ferraz JG, Shaffer E, Vergnolle N. 2007. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest. 117:636-647. Chavez-Pina AE, McKnight W, Dicay M, Castaneda-Hernandez G, Wallace JL. 2007. Mechanisms underlying the anti-inflammatory activity and gastric safety of acemetacin. Br J Pharmacol. 152:930-938. Coppi LC, Thomazzi SM, Ayrizono MD, Coy CS, Fagundes JJ, Goes JR, Franchi GC Jr, Nowill AE, Montes CG, Antunes E, Ferraz JG. 2007. Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 13:211-218. Fiorucci S, Orlandi S, Mencarelli A, Caliendo G, Santagada V, Distrutti E, Santucci L, Cirino G, Wallace JL. 2007. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol. 150:996-1002. Gillrie MR, Krishnegowda G, Lee K, Buret AG, Robbins SM, Looareesuwan S, Gowda DC, Ho M. 2007. Src family kinase-dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. Blood. 110:3426-3435. Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, Altier C, Cenac N, Zamponi GW, Bautista-Cruz F, Lopez CB, Joseph EK, Levine JD, Liedtke W, Vanner S, Vergnolle N, Geppetti P, Bunnett NW. 2007. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol. 578(Pt 3):715-733. Imtiaz MS, Zhao J, Hosaka K, von der Weid PY, Crowe MJ & van Helden DF. 2007. Pacemaking through Ca2+ stores interacting as coupled oscillators via membrane depolarization. Biophys J. . 92:3843–3861. Kalischuk LD, Inglis GD, Buret AG. 2007. Strain-dependent induction of epithelial cell oncosis by Campylobacter jejuni is correlated with invasion ability and is independent of cytolethal distending toxin. Microbiology. 153(Pt 9):2952-2963. Knecht W, Amadesi S, Mohlin J, Skaregarde A, Geddal K, Peterson A, Chapman K, Hollenberg M, Vergnolle N, Cottrell GS, Bunnett NW. 2007. Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia. J Biol Chem. 282):26089-26100. Moreira V, Zamuner SR, Wallace JL, Teixeira CD. 2007. Bothrops jararaca and Crotalus durissus terrificus venoms elicit distinct responses regarding to production of prostaglandins E(2) and D(2), and expression of cyclooxygenases. Toxicon. 49:615-624. Olivo Rdo D, Teixeira CF, Wallace JL, Gutierrez JM, Zamuner SR. 2007. Role of cyclooxygenases in oedema-forming activity of bothropic venoms. Toxicon. 49:670-677. Rattenholl A, Seeliger S, Buddenkotte J, Schon M, Schon MP, Stander S, Vergnolle N, Steinhoff M. 2007. Proteinase-activated receptor-2 (PAR(2)): A tumor suppressor in skin carcinogenesis. J Invest Dermatol. 127:2245-2252. Saifeddine M, Seymour ML, Xiao YP, Compton SJ, Houle S, Ramachandran R, MacNaughton WK, Simonet S, Vayssettes-Courchay C, Verbeuren TJ, Hollenberg MD. 2007. Proteinase-activated receptor-2 activating peptides: Distinct canine coronary artery receptor systems. Am J Physiol Heart Circ Physiol. 293:H3279-H3289. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'neill LA, Perretti M, Rossi AG, Wallace JL. 2007. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21:325-332. Shpacovitch VM, Seeliger S, Huber-Lang M, Balkow S, Feld M, Hollenberg MD, Sarma VJ, Ward PA, Strey A, Gerke V, Sommerhoff CP, Vergnolle N, Steinhoff M. 2007. Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils. Exp Dermatol. 16:799-806. Skinn AC, Vergnolle N, Cellars L, Sherman PM, MacNaughton WK. 2007. Combined challenge of mice with Citrobacter rodentium and ionizing radiation promotes bacterial translocation. Int J Radiat Biol. 83:375-382. Tailor A, Wood KC, Wallace JL, Specian RD, Granger DN. 2007. Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction. Am J Physiol Heart Circ Physiol. 293:H3636-H3642. Wallace JL. 2007. Hydrogen sulfide-releasing anti-inflammatory drugs. 2007. Trends Pharmacol Sci. 28:501-505. Wallace JL. 2007. Building a better aspirin: gaseous solutions to a century-old problem. Br J Pharmacol. 152:421-428. Wallace JL, Caliendo G, Santagada V, Cirino G, Fiorucci S. 2007. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastro. 132:261-271. Wallace JL, Dicay M, McKnight W, Martin GR. 2007. Hydrogen sulfide enhances ulcer healing in rats. FASEB J. 28:501-505. |